28th week of 2012 patent applcation highlights part 46 |
Patent application number | Title | Published |
20120178779 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF - A fused heterocyclic compound of formula (1): | 2012-07-12 |
20120178780 | RAF KINASE INHIBITORS - Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se. | 2012-07-12 |
20120178782 | COMPOSITIONS AND METHODS FOR TREATING PROLIFERATIVE DISEASES - Synergistic pharmaceutical compositions and the methods for preventing and treating proliferative diseases such as cancer and psoriasis. The compositions comprise synergistic combinations of: (i) an acyl-CoA-synthetase enzyme inhibitor (AcsI4), (ii) a compound having an inhibiting effect on enzymes with cyclooxygenase activity (COX); and (iii) a compound selected from a 5-lypoxygenase enzyme (LOX-5) inhibitor and a leukotriene receptor antagonist. | 2012-07-12 |
20120178783 | HDAC INHIBITORS - This invention provides the compound having the structure | 2012-07-12 |
20120178784 | Use Of Inhibitors Of The Renin-Angiotensin System - It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects. | 2012-07-12 |
20120178785 | DERIVATIVES OF N-PHENYLANTHRANILIC ACID AND 2-BENZIMIDAZOLONE AS POTASSIUM CHANNEL AND/OR NEURON ACTIVITY MODULATORS - Compounds, compositions and methods are provided which are useful in the treatment of conditions such as central or peripheral nervous system disorders through the modulation of potassium ion flux through voltage-dependent potassium channels and/or depressing cortical and/or peripheral neuron activity are disclosed. Novel derivatives of N-phenylanthranilic acid are also disclosed. | 2012-07-12 |
20120178786 | Use of tetramic acid derivatives for controlling pests by drenching, drip application, or dip application - Compounds of the formula (I) in which A, B, G, W, X, Y and Z can have the meanings given in the description are highly suitable for controlling animal pests such as insects and/or spider mites and/or nematodes by treating the soil/growth substrate by drenching or drip application or dipping or soil injection. | 2012-07-12 |
20120178787 | MELATONIN AND ITS USE IN PREVENTING POSTOPERATIVE COMPLICATIONS - The invention relates to the use of melatonin, either alone or in combination with at least one compound selected from the group consisting of L-arginine, a physiologically acceptable salt thereof, one or more other physiologically acceptable compounds associated with the synthesis of nitric oxide and mixtures thereof, for the manufacture of a medicament for the therapeutic treatment, prophylactic treatment and/or prevention of postoperative infectious and/or non-infections complications induced by surgical interventions wherein the infectious complications may be pneumonia, wound infection (wound dehiscence), intra-abdominal abscess, and urinary tract infections (UTI) or wherein the non-infectious complication may be anastomotic leak, a pharmaceutical formulation comprising melatonin and at least one compound selected from the group consisting of L-arginine, a physiologically acceptable salt thereof, one or more other physiologically acceptable compounds associated with the synthesis of nitric oxide and mixtures thereof and a method for the therapeutic and/or prophylactic treatment of postoperative infectious and/or non-infectious complications induced by surgical interventions. | 2012-07-12 |
20120178788 | METHOD FOR SUPPRESSING ESTERIFICATION OF PHARMACEUTICAL COMPOSITION - Disclosed are a pharmaceutical composition for external application, an adhesive skin patch and others which are improved in a drug release property, transdermal absorbability and stability of a pharmacologically active ingredient contained therein and can reduce the aggravation of irritation to the skin. Specifically disclosed is an adhesive skin patch comprising a support and an adhesive layer laminated on the support, wherein the adhesive layer contains a pharmaceutical composition for external application. The pharmaceutical composition for external application comprises a pharmacologically active ingredient, an auxiliary component and a pyrrolidone compound, wherein one of the pharmacologically active ingredient and the auxiliary component has a carboxylate group in the molecule and the other has a hydroxy group in the molecule. Preferably, the adhesive layer further comprises a hydrogenated oil. | 2012-07-12 |
20120178789 | NOVEL PYRROLIDINES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE - The present invention relates to compounds of the general formula: (I) wherein ring B, R | 2012-07-12 |
20120178790 | CRYSTALLINE FORM OF A 3-PHENOXYMETHYLPYRROLIDINE COMPOUND - The invention provides a crystalline hydrochloride salt of (S)-3-[(S)-1-(4-chlorophenoxy)-2-methylpropyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases. | 2012-07-12 |
20120178791 | MODULATION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY MICRO-RNA 132 (miR132), MICRO-RNA 145 (miR145) AND MICRO-RNA 212 (miR212) - The present invention related to miR145, miR132, miR212, and the genes or gene products regulated by these miRNAs. miR145 is downregulated in cells infected with HCMV. This downregulation modulates expression of miR145 target genes, including IRS-I. Transfection of cells with a miR145 agent, such as a miR145 mimetic, reduces HCMV replication and protein expression. miR132 and miR212 are upregulated in cells infected with HCMV. This upregulation modulates expression of miR132 and miR212 target genes, including MeCP2 and RICS. Transfection of cells with a miR132 and/or a miR212 antagonist reduces HCMV replication and protein expression. Accordingly, the invention provides methods of attenuating HCMV replication by modulating, for example, miR145, miR132, and/or miR212, and targets thereof. Also provided are methods of detecting an HCMV infection, and compositions and kits useful for attenuating HCMV replication. | 2012-07-12 |
20120178792 | DRG11-RESPONSIVE (DRAGON) GENE FAMILY - This invention features methods and compositions useful for treating and diagnosing diseases of the nervous system, retina, skin, muscle, joint, and cartilage using a Dragon family protein. Protein and nucleic acid sequences of human, murine, zebrafish, and | 2012-07-12 |
20120178793 | NUCLEOTIDE-COCHLEATE COMPOSITIONS AND METHODS OF USE - The present invention is directed to cochleate composition that include a nucleotide. The nucleotide may generally be bound via a linker to a component of the cochleate, or to a lipophilic tail. Additionally or alternatively, the nucleotide may he associated with a transfection agent. The present invention also includes methods for making and using, the compositions provided herein. | 2012-07-12 |
20120178794 | RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders - RNA interference is provided for inhibition of Rho kinase mRNA expression for treating patients with ocular disorders, particularly for treating intraocular pressure, ocular hypertension and glaucoma. Rho kinase mRNA targets include mRNA for ROCK1 and ROCK2. | 2012-07-12 |
20120178795 | RNAI-MEDIATED INHIBITION OF FRIZZLED RELATED PROTEIN-1 FOR TREATMENT OF GLAUCOMA - RNA interference is provided for inhibition of Frizzled Related Protein-1 mRNA expression, in particular, for treating patients having glaucoma or at risk of developing glaucoma. | 2012-07-12 |
20120178796 | SPLICE VARIANTS - We disclose the isolation and characterization of sirtuin 1 [SIRT1] splice variants. | 2012-07-12 |
20120178797 | NOVEL THERAPEUTIC AND DIAGNOSTIC PRODUCTS AND METHODS - The present invention relates to the use of p11 as a drug target as well as a tool for the diagnosis, treatment and development of p11/5-HT receptor related disorders. The invention further relates to p11 knock-out animals as well as p11 transgenic animals and their use as models for the development of novel psychotherapeutic agents, and to methods of diagnosis, prophylaxis and treatment of p11/5-HT receptor related disorders. | 2012-07-12 |
20120178798 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY - Disclosed herein are compounds having a formula: | 2012-07-12 |
20120178799 | ENERGY BEVERAGE WITH CREATINE AND CAFFEINE COMBINATION - The present invention is an energy drink that included both creatine and caffeine, which provides superior energy, concentration and performance over other energy beverages/liquids. The invention can include other vitamins and beneficial additives, but is intended to be unflavored and unsweetened. | 2012-07-12 |
20120178800 | SYNERGISTIC ANTIMICROBIAL COMPOSITION - A synergistic antimicrobial composition having two components. The first component is glutaraldehyde. The second component is 2,6-dimethyl-1,3-dioxan-4-yl acetate. | 2012-07-12 |
20120178801 | COMPOSITIONS AND ITS USE IN TREATING OBESITY OR INDUCING WEIGHT LOSS - The present invention provides a composition comprising polyisoprenylated benzophenone derivative and at least one component selected from stilbene derivative and anthocyanins. The composition inhibits adipogenesis and is therefore useful in treating obesity or weight loss. | 2012-07-12 |
20120178802 | 2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals - Compounds of structural formula (I) useful for the treatment or prophylaxis of viral infection, particularly viral influenza are provided Pharmaceutical preparations thereof and methods for their preparation are also described. The therapeutic effect is achieved via inhibition of viral neuraminidases, also known as viral sialidases. These neuraminidases are classified under the GH34 family of viral enzymes. | 2012-07-12 |
20120178803 | METHOD FOR TREATING BRAIN CANCER OR REDUCING TEMOZOLOMIDE-RESISTANCE OF BRAIN CANCER CELLS - Provided is a method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells in a subject, comprising administrating to the subject an effective amount of an active ingredient selected from the group consisting of (Z)-butylidenephthalide of formula (I), a pharmaceutically acceptable salt of (Z)-butylidenephthalide, a pharmaceutically acceptable ester of (Z)-butylidenephthalide, and combinations thereof: | 2012-07-12 |
20120178804 | NITROGEN-CONTAINING INORGANIC CARRIER MATERIALS - The invention relates to nitrogen-containing inorganic carrier materials, more particularly to inorganic carrier materials containing organically bonded nitrogen, to their preparation and also to their use for stabilizing iodine-containing compounds, and also to binder formulations comprising them and to the use thereof for protecting industrial materials. | 2012-07-12 |
20120178805 | PHENOLIC HYDRAZONE MACROPHAGE MIGRATION INHIBITORY FACTOR INHIBITORS - Provided are various compounds of Formula (I): Also provided are pharmaceutical compositions comprising the above compounds. Additionally, methods of inhibiting macrophage migration inhibitory factor (MIF) activity in a mammal are provided, as are methods of treating or preventing inflammation in a mammal. Further provided are methods of treating a mammal having sepsis, septicemia, and/or endotoxic shock. Also provided are methods of treating a mammal having an autoimmune disease, and methods of treating a mammal having a tumor. | 2012-07-12 |
20120178806 | PHARMACEUTICAL FORMULATIONS COMPRISING 9-CIS-RETINYL ESTERS IN A LIPID VEHICLE - Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans. | 2012-07-12 |
20120178807 | METHOD OF CONTROLLING HARMFUL ARTHROPOD, COMPOSITION, AND ELECTROSTATIC SPRAY DEVICE - A method of the present invention, for controlling a harmful arthropod employs an ester compound which has a specific structure. Accordingly, with the method of the present invention, it is possible to control a wide variety of harmful arthropods effectively, without carrying out any heating process (e.g., a smoking process) for spraying the composition or any pressure process (e.g., a gas-pressure process or a mechanical pressure process) for spraying the compositions. | 2012-07-12 |
20120178808 | FORMULATION COMPRISING FENOFIBRIC ACID, A PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE THEREOF - A formulation comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients is described. Fenofibric acid, the physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion, and the use of this formulation for oral administration of fenofibric acid, a physiologically acceptable salt or derivative thereof are likewise described. | 2012-07-12 |
20120178809 | Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof - Novel 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate compounds corresponding to formula I | 2012-07-12 |
20120178810 | Extended release formulation of an antiepileptic agent - The present invention relates to an extended release formulation of an antiepileptic agent. More particularly, the present invention relates to an extended release formulation of divalproex sodium. The present invention also relates to a process for the preparation of extended release formulation of divalproex sodium. | 2012-07-12 |
20120178811 | METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE TO REDUCE THE RISK OF INFECTION IN AN ELDERLY INDIVIDUAL - Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of β-hydroxy-β-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines. | 2012-07-12 |
20120178812 | Pharmaceutical Formulations Containing Lipoic Acid Derivatives - Pharmaceutical formulations containing lipoic acid derivatives are made. | 2012-07-12 |
20120178813 | LIPID-LOWERING ANTIDIABETIC AGENT - A composition which includes a salt of metformin and the use of the composition for treatment of or use in prediabetes, diabetes, lowering triglycerides and/or other conditions in mammals. | 2012-07-12 |
20120178814 | Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease - The invention relates to substituted phenoxyacetic acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation. | 2012-07-12 |
20120178815 | Compositions of (-)-E-10-OH-NT and Methods for Their Synthesis and Use - This present disclosure provides compositions comprising E-10-OH-NT metabolites of AT and NT, methods for their synthesis and methods for their use. | 2012-07-12 |
20120178816 | CARBAMIDE PEROXIDE TREATMENTS FOR THE REPRODUCTIVE TRACT - Disclosed are methods of maintaining fertility or treating retained placenta, reproductive tract infection, or reproductive tract inflammation in an animal by administering carbamide peroxide to the reproductive tract of the animal. The carbamide peroxide administration removes placental remains on the uterine wall, protects against or treats reproductive tract infection, and protects against or treats reproductive tract inflammation such as metritis, and thereby maintains fertility in the animal. | 2012-07-12 |
20120178817 | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES - A biocidal composition comprising 2,2-dibromomalonamide and a surface active biocide, and its use for the control of microorganisms in aqueous and water-containing systems. | 2012-07-12 |
20120178818 | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES - A biocidal composition comprising 2,2-dibromomalonamide and sodium ortho-phenylphenol, and its use for the control of microorganisms in aqueous and water-containing systems. | 2012-07-12 |
20120178819 | Selective, Lipophilic, and Long-Acting Beta Agonist Monotherapeutic Formulations and Methods for the Cosmetic Treatment of Adiposity and Contour Bulging - Provided herein are pharmaceutical and cosmetic formulations and methods for regional adiposity reduction and treatment of body contour defects such as abdominal bulging; comprising an injectable formulation, said formulation comprising: an active ingredient that consists essentially of an adipose tissue-reducing amount of one or more lipophilic long-acting selective beta-2 adrenergic receptor agonists, or salts, solvates, or polymorphs thereof; and one or more subcutaneously acceptable inactive ingredients. | 2012-07-12 |
20120178820 | METHOD FOR TREATING ARTHRITIS - The present invention relates to the use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: wherein X is H or OH; R1, R2, R3, R4 and R5 are the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, electron donor groups such as alkoxy having 1-5 carbon atoms or hydroxy, electron acceptor groups selected from cyano, nitro, trifluoroalkyl or amide; alkylamino, benzoyloxy, nitroxy, phenyl or sulpho; and the pharmacologically active salts thereof. | 2012-07-12 |
20120178821 | POLYMORPHIC FORM OF TOREMIFENE CITRATE AND PROCESS FOR ITS PREPARATION - The present invention provides a polymorphic form of toremifene citrate and processes for its preparation. It also relates to an improved process for the preparation of the Z isomer of the toremifene base, free of E isomer, and its pharmaceutically acceptable salts. | 2012-07-12 |
20120178822 | Co-Processed Excipient Compositions - An oral solid dosage form having improved dissolution profile and a method of producing the same are provided. The present invention particularly provides a co-processed excipient composition and a method of producing the same. More particularly, it relates to a co-processed binary mixture of crosslinked polyvinylpyrrolidone and calcium silicate; wherein the weight ratio of crosslinked polyvinylpyrrolidone and calcium silicate is in the range of 1:1 to 20:1. The binary mixture when combined with a poorly soluble drug enhances its dissolution and extent of release. | 2012-07-12 |
20120178823 | GEL-LIKE COMPOSITION - Provided is a gel-like composition which has such satisfactory safety, storage stability, and versatility as to be widely used typically as cosmetics and pharmaceutical vehicles. The gel-like composition contains a polyglycerol monoalkyl ether represented by following Formula (1): | 2012-07-12 |
20120178824 | HYDROGELS BASED ON ESTERS OF POLYISOBUTENESUCCINIC ACID - The present invention relates to the use of esters of polyisobutenesuccinic acid for producing hydrogels, and to the use of such hydrogels for cleaners and care compositions for the home (so-called homecare products), for cosmetics, and also for medical products. | 2012-07-12 |
20120178825 | CYCLOHEXANEDIMETHANOL-BASED HYDROPHILIC POLYURETHANE UREA - The invention relates to novel polyurethane ureas which can be used in the production of hydrophilic coatings on various substrates. | 2012-07-12 |
20120178826 | Wound Dressing Compositions Suitable for Use in Negative Pressure Wound Therapy - The present invention relates to a wound dressing composition suitable for use in a negative pressure wound therapy application comprising hydrocolloids, hot melt acrylic adhesives, tackifiers, elastomeric binders, and extenders, and if desired, active ingredients. | 2012-07-12 |
20120178827 | Solid Pharmaceutical Preparations Comprising Amphiphilic Copolymers On The Basis Of Polyethers In Combination With Surfactants - Dosage forms comprising formulations of sparingly water-soluble active ingredients in a polymer matrix composed of polyether copolymers, said polyether copolymers being obtained by free-radically initiated polymerization of a mixture of 30 to 80% by weight of N-vinyllactam, 10 to 50% by weight of vinyl acetate and 10 to 50% by weight of a polyether, and of at least one surfactant, in which the sparingly water-soluble active ingredient is present in amorphous form in the polymer matrix. | 2012-07-12 |
20120178828 | PROCESS FOR THE PREPARATION OF A FLAVORING CONCENTRATE, AND A FLAVORING CONCENTRATE - The present invention relates to processes for the preparation of a flavoring concentrate, to a flavoring concentrate which can be prepared by a process according to the invention, to products comprising one or more flavoring concentrates according to the invention, and to processes for the concentration of flavoring and/or aromatic substances. | 2012-07-12 |
20120178829 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION - The instant invention pertains to novel bi- or tricyclic sterically hindered alkoxyamines, their precursors, a process for their preparation and their use as light stabilizers for polymers or coatings, as flame retardants, as peroxide substitutes (rheology modifiers) or carbon radical scavengers. | 2012-07-12 |
20120178830 | LIQUID COMPOSITION TO BE FILLED IN SOFT CAPSULES - Disclosed is a liquid composition which is intended to be filled in soft capsules and comprises an oil-insoluble ingredient dispersed in an edible oil, a reactive monoglyceride, and a triglycerol fatty acid ester having a monoester content of 50% or more. The liquid composition to be filled in soft capsules does not comprise bees wax but has a dispersion stability of the oil-insoluble ingredient equal to or higher than that of a conventional composition in which bees wax is used. | 2012-07-12 |
20120178831 | PROCESS FOR PRODUCING HYDROCARBON OIL, AND SYNTHESIS REACTION SYSTEM - A process for producing a hydrocarbon oil from a feedstock gas containing carbon monoxide gas and hydrogen gas using a Fischer-Tropsch synthesis reaction, the process including a hydrocarbon synthesis step of synthesizing hydrocarbons by reacting the carbon monoxide gas and hydrogen gas contained in the feedstock gas within a catalyst particle-containing slurry contained inside a reactor, a powdered particle removal step of filtering the slurry extracted from a top section of a slurry bed inside the reactor, trapping and separating powdered particles formed by powdering of the catalyst particles to obtain liquid hydrocarbons, a catalyst particle trapping step of filtering the slurry extracted from a position lower than the top section of the slurry bed, trapping and separating the catalyst particles to obtain liquid hydrocarbons, and a catalyst particle return step of returning the trapped catalyst particles in the catalyst particle trapping step to the reactor, and a hydrocarbon recovery step of mixing the liquid hydrocarbons obtained in the powdered particle removal step and the liquid hydrocarbons obtained in the catalyst particle trapping step to recover a hydrocarbon oil. | 2012-07-12 |
20120178832 | Methods and systems for producing energy from carbon dioxide - A method and system for producing a liquid fuel comprising:
| 2012-07-12 |
20120178833 | PROCESS FOR THE PRODUCTION OF METHANE - A process for the production of methane comprising reacting at least part of a feed gas containing carbon monoxide and hydrogen in an internally cooled methanation reactor containing a nickel comprising methanation catalyst to produce a product gas containing methane, cooling the internally cooled methanation reactor with water, wherein the water enters the internally cooled methanation reactor at a temperature in the range from 20-120° C. below its boiling temperature. | 2012-07-12 |
20120178834 | Membranes, Coatings and Films and Methods for Their Preparation - There are provided herein selective membranes, such as composite membranes, and/or films and processes for their preparation. The membranes and/or films have a given morphology which may be stabilized, for example against swelling and chemical degradation, by covalent crosslinking and optionally, in addition, by hydrophobization. There is provided a membrane and/or film and a process for the preparation thereof, the membrane and/or film include an ionomer and/or polyelectrolyte crosslinked through aryl-aryl (—Ar-Ar-), aryl-ether-aryl (—Ar—O—Ar—) and/or aryl-sulfide-aryl (—Ar—S—Ar—) bonds. | 2012-07-12 |
20120178835 | USE OF BRANCHED ADDITION COPLYMERS IN FILMS AND MEMBRANES - The present invention relates to branched addition copolymers which can be cured post synthesis to form films or membranes, methods for their preparation, compositions comprising such copolymers and their use in film or membrane preparation. | 2012-07-12 |
20120178836 | INTERCONNECTED POROUS NON-DEGRADABLE POLY(VINYL) ALCOHOL IMPLANT AND METHOD OF MANUFACTURE - The present invention relates to a method of manufacture of an interconnected porous non-biodegradable polymer implant suitable for implantation into a mammal for the treatment, repair or replacement of defects or injury in musculoskeletal tissue, wherein the mechanical properties of the implant can be controlled by varying the concentration of the non-biodegradable polymer and/or varying the duration and number of freeze-thaw cycles and the interconnected porous non-biodegradable polymer implant has sufficient percent porosity and pore diameter to facilitate integration of cells and attachment within the mammal via ingrowth of surrounding tissue. The present invention also relates to an implant manufactured by the method. | 2012-07-12 |
20120178837 | HIGH MELT STRENGTH POLYESTERS FOR FOAM APPLICATIONS - The present invention relates to a branched polyethylene terephthalate-co-isophthalate for use in the manufacture of foamed articles. The branched polyethylene terephthalate-co-isophthalate can be characterized by a composition comprising i) a polyethylene terephthalate-co-isophthalate comprising from about 5 to about 15 weight % of an isophthalic acid, and ii) a branching agent comonomer, wherein the branching agent comonomer is a polyhydric alcohol having functionality of 3 or more and the polyhydric alcohol is present in an amount of from 0.005 to about 0.01 equivalents per mole of total diacids. Other embodiments of the present invention include foamed articles produced from these compositions and processes to produce these compositions and the foamed articles. | 2012-07-12 |
20120178838 | FOAMABLE RUBBER COMPOSITION - The invention is related to an elastomer composition comprising an elastomeric polymer comprising ethylene and α-olefin derived units, a curing package and a blowing agent wherein the blowing agent comprises a compound containing water of crystallization. | 2012-07-12 |
20120178839 | Process For Producing Flexible Polyurethane Foam - A composition and process useful to make flexible polyurethane foams and in particular flexible molded polyurethane foams is disclosed. The usage of dipolar aprotic liquids such as DMSO, DMI, sulfolane, N-methyl-acetoacetamide, N,N-dimethylacetoacetamide as well as glycols containing hydroxyl numbers OH#≦1100 as cell opening aides for 2-cyanoacetamide or other similar molecules containing active methylene or methine groups to make a polyurethane foam is also disclosed. The advantage of using cell opener aids results in a) no foam shrinkage; b) lower use levels of cell opener; c) foam performance reproducibility d) optimum physical properties. In addition, combining the acid blocked amine catalyst together with the cell opener and the cell opener aid results in a less corrosive mixture as well as provides a method that does not require mechanical crushing for cell opening. | 2012-07-12 |
20120178840 | POLYMER-DISPERSED POLYOL AND PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAM - To provide a polymer-dispersed polyol made by using materials derived from a natural fat/oil, which has a low viscosity, without lowering the biomass degree and without impairing the performance of a flexible polyurethane foam to be obtained. Further, to provide a process for producing a flexible polyurethane foam using the polymer-dispersed polyol. A polymer-dispersed polyol, comprising polymer particles dispersed in a matrix containing a polyol (a1) derived from a natural fat/oil and an epoxidized natural fat/oil (x). And, a process for producing a flexible polyurethane foam, which comprises reacting a polyol containing the above polymer-dispersed polyol and a polyisocyanate compound in the presence of a catalyst and a blowing agent. | 2012-07-12 |
20120178841 | THERMALLY DISAPPEARING RESIN PARTICLE - The present invention is a directed to a method of producing a thermally decomposing resin particle, which comprises polymerizing a polyoxyalkylene macromonomer having a functional group alone or in combination with another polymerizable monomer in a solvent. | 2012-07-12 |
20120178842 | HALOGEN-FREE, FLAME-PROOF POLYMER FOAMS CONTAINING AT LEAST ONE OLIGOPHOSPHORUS COMPOUND - Halogen-free, flame-retardant polymer foams which comprise, as flame retardant, at least one cyclic or acyclic oligophosphorus compound, and processes for their production. Examples of suitable oligophosphorus compounds are those having the structure Ia, Ib, or Ic: | 2012-07-12 |
20120178843 | Polyolefin treatment process for uniform crosslinking - A process produces a block of polyolefin material with uniform crosslinking, which may be uniform between and within polymer chains in the polyolefin material. Steps include: providing an oven; placing the block into the oven; preheating the block to a uniform temperature above the melting point; further heating the block to a temperature at least 30 degrees Centigrade above the melting point; cooling the block to room temperature under an inert gas; and removing oxidized material from surface of the block. Optional steps include: subjecting the block to radiation before placing the block into the oven; removing the gases from the oven on a continuous or stepwise basis; controlling the purge gas flow out of the oven; and determining a heating time period for the block by subjecting control blocks to the same process and analyzing them after various heating times. | 2012-07-12 |
20120178844 | MACROPHOTOINITIATORS - The invention pertains to high-molecular photoinitiator compounds comprising a photoactive moiety Q and an amine functionality, preferably a tertiary amino group, where the photoactive moiety Q is a benzoyl photoactive moiety. | 2012-07-12 |
20120178845 | COMPOSITIONS AND METHODS FOR USE IN THREE DIMENSIONAL MODEL PRINTING - A radiation curing composition suitable for building a three-dimensional object by a solid freeform method is disclosed. The composition includes one or more mono-functional monomers where a respective polymer has a Glass Transition Temperature higher than about 60° C., one or more di-functional oligomers where a respective polymer has a Glass Transition Temperature lower than about 40° C. and a phase separation inducing component. The phase separation may be induced during curing, resulting in a non-clear cured material having an improved impact strength and higher elongation, when compared to similar compositions without a phase separation including component. | 2012-07-12 |
20120178846 | Polyolefin treatment process for uniform crosslinking - A process produces a block of polyolefin material with uniform crosslinking, which may be uniform between and within polymer chains in the polyolefin material. Steps include: providing an oven; placing the block into the oven; preheating the block to a uniform temperature above the melting point; further heating the block to a temperature at least 30 degrees Centigrade above the melting point; cooling the block to room temperature under an inert gas; and removing oxidized material from surface of the block. Optional steps include: subjecting the block to radiation before placing the block into the oven; removing the gases from the oven on a continuous or stepwise basis; controlling the purge gas flow out of the oven; and determining a heating time period for the block by subjecting control blocks to the same process and analyzing them after various heating times. | 2012-07-12 |
20120178847 | POLYUREA-BASED FABRIC GLUE - The present invention relates to a polyurea system, the use of such a polyurea system for sealing, linking, gluing, or covering of cellular tissue, and a dosing system having two chambers for a polyurea system such as this. The polyurea system comprises as components: A) an isocyanate-functioning prepolymer, which can be derived by reacting aliphatic isocyanates with polyoles, and B) an amino-functioning ester of aspartic acid. According to the invention, water and/or tertiary amine is added to the system, in order to increase the reacting speed of the prepolymer with the amino-functioning ester of aspartic acid while decreasing the setting time at the same time. | 2012-07-12 |
20120178848 | BUTYL IONOMERS FOR USE IN REDUCING A POPULATION OF AND/OR PREVENTING ACCUMULATION OF ORGANISMS AND COATINGS MADE THEREFROM - The invention relates to the use of butyl ionomers or partially halogenated butyl ionomers in reducing a population of and/or preventing accumulation of organisms. The organisms may be bacteria, algae, fungi, mollusca or arthropoda. The invention also relates to coatings for shaped articles comprising the butyl ionomers. | 2012-07-12 |
20120178849 | RESIN POWDER CONTAINING ALUMINUM SALT, PROCESS FOR PRODUCTION OF THE SAME, AND RESIN COMPOSITION, PHOSPHORUS ADSORBENT, ANTIBACTERIAL AGENT OR ANTIFUNGAL AGENT COMPRISING THE SAME - An aluminum salt-containing resin powder of the present invention includes: at lest one matrix resin component selected from regenerated collagen, polyvinyl alcohol and carboxymethyl cellulose; and an aluminum salt. The aluminum salt is chemically bonded to the matrix resin component, and the resultant is powdered. A resin composition of the present invention includes 0.1 wt % or more and 80 wt % or less of the aluminum salt-containing resin powder and 20 wt % or more and 99.9 wt % or less of a resin other than the aluminum salt-containing resin. Thus, the present invention provides an aluminum salt-containing resin powder having a high phosphorus adsorption property a high antibacterial property and a high antifungal property, and a resin composition containing the aluminum salt-containing resin powder. | 2012-07-12 |
20120178850 | ARTIFICIAL MARBLE AND METHOD OF MANUFACTURING THE SAME - Disclosed are artificial marble and a method of manufacturing the same. The artificial marble has a natural aesthetic pattern like a flowing pattern to exhibit an equivalent or superior texture to that of natural marble. Further, as the artificial marble is prepared by placing an uncured marble resin sheet or block in a mold and pressing, the artificial marble has excellent mechanical strength and gloss and does not contain bubbles therein even after pressing at a low temperature and a low pressure. | 2012-07-12 |
20120178851 | RESIN WITH HIGH HEAT TRANSFER - A resin with high heat transfer and potential is specially designed to transfer heat between two layers of different nature. One of the layers acts as an energy receiver via the outer face thereof and an energy emitter via the inner face thereof, and the other layer acts as a receiver of the accumulated energy in the resin, acting as connecting bridge between the two layers. The resin with high heat transfer of the invention includes granular particles of slate and preferably granular particles of a metallic nature, in a polymeric matrix. | 2012-07-12 |
20120178852 | PROCESS FOR PREPARING EPISULFIDE RESINS - A process for converting epoxy resin to episulfide resin through reactive melt extrusion of a solid epoxy resin with a sulfur donating compound. The resulting resin provides for an application that utilizes the resulting extruded episulfide resin as a low application temperature resin for powder coatings applications. | 2012-07-12 |
20120178853 | SOLVENTLESS ONE LIQUID TYPE CYANATE ESTER-EPOXY COMPOSITE RESIN COMPOSITION - The present invention is a solventless one liquid type cyanate ester-epoxy resin composition having high thermal resistance as well as excellent storage stability and curing properties, which contains (A) cyanate ester, (B) epoxy resin, (C) guanidine compounds and (D) at least one kind of phenol compounds selected from a group consisting of phenol compounds represented by the following general formulae. In the general formulae, 1 is an integer selected from 0 to 4, R | 2012-07-12 |
20120178854 | IRON(III)-COMPLEXING AGENTS FOR STABILIZING COMB POLYMERS IN MINERAL BINDING AGENTS - Compositions including a comb polymer and an Fe(III)-complexing agent X selected from the group consisting of thiocyanates, condensed phosphates, amines, amino acetic acids, oxycarboxylic acids and compounds of the formula (V). The invention also relates to a method for stabilizing comb polymers in the presence of Fe(III) using such Fe(III)-complexing agents X. | 2012-07-12 |
20120178855 | WOOD-PLASTIC COMPOSITE WITH IMPROVED THERMAL AND WEATHERING RESISTANCE AND METHOD OF MAKING THE SAME - Thermoplastic compositions containing a natural filler and, more specifically, thermoplastic compositions containing a natural filler and having improved thermal and weathering resistance. The wood-plastic composites utilize a cellulose filler, such as wood flour, and vegetal fibers, such as Curauá fiber, as a reinforcement filler. The issues with regard to thermal degradation of cellulose during processing are reduced through the use of specific additives designed to improve its performance during processing. Additionally, other additives are included to improve the UV resistance. Specific combinations of thermal stabilizer and UV additive are provided that enhance the thermal resistance and weathering resistance of the compositions as compared to prior art systems. | 2012-07-12 |
20120178856 | CELLULOSE FIBERS WITH AN ENHANCED METERING CAPABILITY, PROCESSES FOR THEIR PRODUCTION AND THEIR USE TO REINFORCE COMPOUND MATERIALS - The present invention relates to cellulose fibers with an enhanced metering capability, a process for the production of these and the use of these for the reinforcement of compound materials, in particular thermoplastic polymers. | 2012-07-12 |
20120178857 | HYDROSEED SUBSTRATE AND METHOD OF MAKING SUCH - A Hydroseed substrate for mixing with other ingredients such as water, seeds, fertilizer, wetting agents and dye, to produce Hydroseeding slurry is disclosed. The substrate includes cellulose materials (e.g. cardboard, paper and/or wood) and an absorbent. The absorbent is a super absorbent polymer such as linear polyacrylamide (—CH | 2012-07-12 |
20120178858 | Isosorbide-Plasticized Starch And Uses Thereof - Starch plasticized, wholly or in part, with isosorbide, isomannide, isoidide, or a mixture thereof is disclosed. Blends of the plasticized starch and a synthetic polymer, like a polyolefin, also are disclosed. | 2012-07-12 |
20120178859 | CURABLE RESINS AND ARTICLES MADE THEREFROM - Optical devices of excellent optical and physical properties produced from cured resins are disclosed. The resins and/or the cured hybrid polymer material made with the resins are characterized by a high level of cycloaliphatic-containing groups. Specific additives that can participate in crosslinking the curable polysiloxane provide additional physical property advantages. | 2012-07-12 |
20120178860 | REINFORCED THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE - The reinforced thermoplastic resin composition of the present invention includes: 50 to 90% by weight of a polycarbonate resin (A); 10 to 50% by weight of a graft copolymer mixture (B) (provided that a total amount of the component (A) and the component (B) accounts for 100% by weight) which is obtained by graft-polymerizing an aromatic alkenyl compound monomer unit (a) and a vinyl cyanide compound monomer unit (b) onto a rubber polymer (B1); and 6 to 22 parts by weight of an inorganic filler (D) which has been surface-treated with a water-soluble polyamide, relative to the total of 100 parts by weight of the polycarbonate resin (A) and the graft copolymer mixture (B). There is provided a reinforced thermoplastic resin composition exhibiting excellent moldability, generates a minimal amount of gas during molding, and also being capable of improving the rigidity of the resulting molded article and the impact resistance when dropping the product. | 2012-07-12 |
20120178861 | POLYOLEFIN RESIN COMPOSITION - A polyolefin resin composition is excellent in processing cycle and mechanical characteristics and provides small deformation during molding, i.e., small deformation due to anisotropicity in shrinkage factors. Specifically, provided is a polyolefin resin composition obtained by incorporating 0.01 to 10 parts by mass of, preferably 0.05 to 5 parts by mass of (B) a compound represented by the following formula (I) with respect to 100 parts by mass of (A) a polyolefin resin, preferably a polypropylene. The polyolefin resin composition may also contain, if necessary, a phenolic, phosphorus, thioether or hydroxyamine antioxidant, an ultraviolet absorbent, a hindered amine light stabilizer, or other nucleator, or the like. | 2012-07-12 |
20120178862 | RESIN COMPOSITION USED FOR PEELABLE COATING AND COMPOUNDING PROCESS THEREOF - The present invention provides a resin composition used for peelable coating and compounding process thereof. The composition includes the following components: (a) 100 parts by weight of film-forming resin containing at least one acrylic resin; (b) 0.1-40 parts by weight of at least one separating agent, which is polypropylene glycol or glycerin fatty acid ester or their mixtures; and (c) 40-60 parts by weight of at least one solvent. The peelable coating formed from the resin composition has excellent water resistance and excellent peeling performance even under the condition of prolonging storage period. | 2012-07-12 |
20120178863 | INKJET COMPOSITION FOR FORMING A TRANSPARENT FILM, AND TRANSPARENT FILM FORMED FROM SAME - An inkjet composition for a transparent film includes a) a binder polymer, b) a polymerizable monomer, c) a polymerization initiator, and d) a solvent having a boiling point of 150° C. or more. Using the inkjet composition according to the embodiments of the present invention, the transparent film may be directly manufactured at a desired position by using the inkjet process, while using a small amount of ink, thereby increasing the efficiency of the manufacturing process. Also, due to the excellent jetting properties thereof, it is advantageous to forming the transparent film. Furthermore, the excellent transmittance and heat resistance may be obtained. | 2012-07-12 |
20120178864 | CORROSION CONTROL IN AND SELENIUM REMOVAL FROM FLUE GAS WET SCRUBBER SYSTEMS - A method and composition for the reduction of the emission of selenium into the environment from the burning of fossil fuels with the use of two chemistries, either individually or in combination with each other. The method uses polydithiocarbamic compounds, including polydithiocarbamic compounds derived from a polymer produced from acrylic-x and alkylamine in conjunction with a scrubber process to capture selenium and reduce its emission in aqueous phase blowdown. The method and composition also helps reduce corrosion in the scrubber process. | 2012-07-12 |
20120178865 | ANTI-SCORCH COMPOSITIONS, METHODS OF MAKING THE SAME, AND ARTICLES PREPARED FROM THE SAME - The invention provides a composition comprising at least the following: A) interpolymer comprising, in polymerized form, ethylene, an α-olefm and a nonconjugated polyene; B) sulfur; C) at least one phase transfer catalyst (PTC) selected from the group consisting of the following: Formula (1), wherein each R group is, independently, an alky group having from 4 to 32 carbon atoms, and X is a halogen ion; Formula (2), Wherein the R group is an alky group having from 4 to 32, and X is a halogen ion; Formula (3), wherein R1 is the alky group having from 1 to 4 carbon atoms, R2 is an alkyl group having from 1 to 32 carbon atoms, and X is a halogen ion; and combinations of (1), (2) and (3); and D) at least one primary accelerator selected from the group consisting of the following: Formula (a), wherein R is H, or a heterocyclic substituent; Formula (b), wherein M is Zn | 2012-07-12 |
20120178866 | RESIN COMPOSITION - The resin composition of the present invention is characterized by comprising (A) biodegradable resin, (B) at least one inorganic filler selected from a fibrous inorganic filler, a plate-like inorganic filler, a rod-like inorganic filler and a granular inorganic filler, or an organic filler having water repellency, and (C) a di- or higher functional compound or resin having an isocyanate group. The resin composition of the present invention comprises a biodegradable resin as a main resin component, but can provide molded articles excellent in hydrolysis resistance, mechanical characteristics, and dimensional stability. | 2012-07-12 |
20120178867 | Process for Producing Crosslinked, Melt-Shaped Articles - Crosslinked, melt-shaped articles are manufactured by a process that does not require the use of post-shaping external heat or moisture, the process comprising the steps of: A. Forming a crosslinkable mixture of a 1. Organopolysiloxane containing one or more functional end groups; and 2. Silane-grafted or silane-copolymerized polyolefin; and B. Melt-shaping and partially crosslinking the mixture; and C. Cooling and continuing crosslinking the melt-shaped article. Crosslinking is promoted by the addition of a catalyst to the mixture before or during melt-shaping or to the melt-shaped article. | 2012-07-12 |
20120178868 | Crosslinked, Melt-Shapped Articles and Compositions for Producing Same - Disclosed is a crosslinkable mixture comprising a polyolefin, an alkoxysilane, an organopolysiloxane, a free radical initiator and a liquid polymer modifier. The organopolysiloxane contains two or more hydroxyl end groups. When the crosslinkable mixture is melt-shaped, a unique crosslinked composition is formed. The liquid polymer modifier improves flexibility of the melt-shaped article without decreasing dielectric strength. | 2012-07-12 |
20120178869 | POLYSILOXANE COATING WITH HYBRID COPOLYMER - A coating includes the reaction product of (a) a hybrid copolymer incorporating (i) a first monomer including a hydroxy-functional organoacrylate and (ii) a second monomer including an organoalkoxysilane and (b) a second material including an organofunctional alkoxysilane. The first monomer can be a hydroxy functional acrylate and/or a hydroxyalkylacrylate. The second monomer can be a trialkoxysilane. The second material can be a trialkoxysilane. | 2012-07-12 |
20120178870 | AROMATIC POLYESTER RESIN COMPOSITION - An aromatic polyester resin composition, comprising: a melt-kneaded product of 99-70 wt. parts of an aromatic polyester resin and 1-30 wt. parts (providing a total of 100 wt. parts together with the aromatic polyester resin) of a polyglycolic acid resin, wherein the aromatic polyester resin is an aromatic polyester resin polymerized with an antimony compound (catalyst), the polyglycolic acid resin is a polyglycolic acid resin obtained by ring-opening polymerization of glycolide, and the composition further contains a metal-deactivating agent in a proportion of 17-500 mol. % with respect to the antimony in the aromatic polyester resin. As a result, gas generation during the melt-processing of a composition obtained by adding a relatively small amount of polyglycolic acid resin to an aromatic polyester resin is effectively suppressed to provide an aromatic polyester resin composition with a good gas-barrier property. | 2012-07-12 |
20120178871 | THERMALLY CURED UNDERLAYER FOR LITHOGRAPHIC APPLICATION - An etch resistant thermally curable Underlayer composition for use in a multiplayer lithographic process for producing a photolithographic bilayer coated substrate, the composirion being a composition of:
| 2012-07-12 |
20120178872 | HYDROPHOBIC POLYMER FOR PRODUCING MEDICAL DEVICES VISIBLE IN MRI - The present invention relates to a hydrophobic polymer used in particular to produce and/or coat medical devices, in particular implantable medical devices, that are visible in magnetic resonance imaging, characterized in that it comprises at least one monomer unit on which is grafted a chelating ligand of a paramagnetic ion complexed with such a paramagnetic ion, said monomer unit having at least one carbonyl group, said monomer unit comprising, prior to grafting, at least one hydrogen atom in the a position of said at least one carbonyl group, and said grafting of the chelating ligand taking place in the area of said at least one hydrogen atom in the a position of said at least one carbonyl group. | 2012-07-12 |
20120178873 | Copolymers of Styrene With Alkyl Acrylates and/or Alkyl Methacrylates - A styrenic copolymer composition including at least one alkyl acrylate and/or alkyl methacrylate comonomer, in which the styrenic copolymer composition is optically clear and has at least two times the impact strength compared to general-purpose polystyrene. | 2012-07-12 |
20120178874 | STRUCTURAL HYDROGEL POLYMER DEVICE - The present invention relates generally a manufacturing process which results in a completely hydrogel polymer device that maintains lumen patency which allows for numerous applications. Catheters and stents are particular examples, and their composition, mechanical characteristics, and the significantly unique ability to conduct and allow fluids to pass from one end to the other without physiological rejection, inflammation, or manifestation of complications due to implant or otherwise undesirable outcomes when used for ambulatory and or therapeutic interventions is the purpose of the invention. | 2012-07-12 |
20120178875 | PRODUCT COMPRISING ULTRAFINE NATURAL GLASS - A product including ultrafine natural glass, methods of producing the ultrafine natural glass, and methods of use thereof are provided. The product may have, for example, a small top cut (d | 2012-07-12 |
20120178876 | POLYAMIDE COPOLYMER AND MOLDED PRODUCT - To provide a polyamide copolymer that is excellent in terms of rigidity after water absorption (water absorption rigidity) and rigidity under high temperature use (thermal rigidity). A polyamide copolymer comprising a dicarboxylic acid component unit containing an (a) adipic acid unit, a (b) isophthalic acid unit and a (c) 1,4-cyclohexanedicarboxylic acid unit, and a diamine component unit, wherein a relationship between a content (mol %) of the (b) and a content (mol %) of the (c) in a total of 100 mol % of the dicarboxylic acid component unit containing the (a), the (b) and the (c) satisfies following formula (1): | 2012-07-12 |
20120178877 | THERMALLY CONDUCTIVE NANOCOMPOSITE COATING COMPOSITIONS - Thermally conductive nanocomposite coating compositions comprising an adhesive system with embedded nanoparticles. The adhesive system comprising a mixture of 40-60% urethane prepolymer, and 40-60% polymeric methylene diphenyl diisocyanate. The nanocomposite composition providing an elastomeric coating which is resistant to corrosion, water, oxygen, acids and salts, and which provides thermal conductivity. | 2012-07-12 |
20120178878 | PROCESS FOR PRODUCING SILICA AND SULFUR CONTANING RUBBER COMPOSITION - A process for producing a rubber composition which includes mixing a silica and a sulfur-containing organic silicon compound represented by general formula (1): | 2012-07-12 |
20120178879 | PROCESS FOR RECYCLING PRODUCT STREAMS SEPARATED FROM A HYDROCARBON-CONTAINING FEED STREAM - The present invention relates to a process for recycling product streams that have been separated from a hydrocarbon-containing feed stream comprising olefin monomer, olefin co-monomer, hydrocarbon diluent and components such as H | 2012-07-12 |